发现了用于骨质疏松症治疗的新型甲素K抑制剂,使用基于深度学习的策略
Qi Li1,2, Xue-Chun Han1,2, Si-Rui Zhou1,2
1Beijing Key Laboratory of Diabetes Research and Care, Beijing Diabetes Institute, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Expert opinion on drug discovery
|July 2, 2025
概括
研究人员开发了一种深度学习模型,以找到新的骨质疏松症甲素K (CTSK) 抑制剂. 奎尔,γ-烯酸 (GLA) 和异硫酸 (BITC) 显示出作为强大的CTSK抑制剂和减少骨质细胞形成的前景.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 计算化学计算化学
背景情况:
- 甲素K (CTSK) 是骨质疏松症治疗的关键标,因为它在骨质细胞中表达很高.
- 目前,没有任何CTSK抑制剂被批准用于临床使用,这突出了未满足的医疗需求.
研究的目的:
- 通过深度学习和实验验证的结合,识别新的甲素K (CTSK) 抑制剂.
- 评估已识别的化合物对CTSK的抑制潜力和作用机制.
- 评估化合物在抑制骨质结晶生成方面的有效性.
主要方法:
- 开发了一个用于CTSK抑制的预测深度学习模型 (Chemprop).
- 通过实验选了100个预测的分子,随后进行了酶动力学,分子对接和分子动力学模拟.
- 使用RAW264.7细胞进行了体外分析,以评估RANKL诱导的骨质结晶生成的抑制.
主要成果:
- 确定了六种具有度依赖的CTSK抑制活性的化合物.
- 奎尔塞丁,γ-烯酸 (GLA) 和二酸 (BITC) 成为最强大的抑制剂.
- 酶动力学和分子动力学揭示了瑞和BITC的明显抑制机制和稳定的活性位点相互作用.
- 奎尔塞丁和GLA在体外显著抑制了骨质细胞形成.
结论:
- 成功开发了一种用于预测CTSK抑制剂的深度学习模型.
- 奎思丁,GLA和BITC被认为是骨质疏松症治疗的有前途的治疗候选药物.
- 这项研究为开发针对CTSK的新型骨质疏松症治疗提供了基础.
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...